The presence of a putative TGFβ mechanism in two such disparate groups of patients as metastatic breast cancer and pediatric burns raises the possibility that this mechanism could be active in a wider range of resorptive bone diseases or may contribute to a cycle of muscle wasting and resorptive bone loss in neuromuscular diseases. Here, TGFB1 is linked to neuromuscular disease.